The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review.

Swildens, Kyra X; Sillevis Smitt, Peter A E; van den Bent, Martin J; French, Pim J; Geurts, Marjolein

Swildens, Kyra X; Sillevis Smitt, Peter A E; van den Bent, Martin J; French, Pim J; Geurts, Marjolein.

Afiliación

Swildens KX; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Sillevis Smitt PAE; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
van den Bent MJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
French PJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Geurts M; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Neurooncol Adv ; 4(1): vdac087, 2022.

Article en En | MEDLINE | ID: mdl-35990704

Palabras clave

checkpoint inhibitors; corticosteroids; dexamethasone; glioblastoma; immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Neurooncol Adv Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google